glp-1 drugs and muscle loss don't steal your muscle. Weight does. A 2026 meta-analysis in Diabetes, Obesity Metabolism compared lean mass changes between GLP-1 drugs and intensive lifestyle intervention in adults with overweight Weight Reduction with GLP-1 Agonists

94,265,266,267 Moreover, in vascular cells, upregulation of growth factors like PDGF has been noted, which can promote smooth muscle cell proliferation and atherosclerosis

YalshettiSThokchomBBhaviSMSinghSRPatilSRHariniBPet alMicrowave-Assisted Synthesis, Characterization and In Vitro Biomedical Applications of Hibiscus Rosa-Sinensis Linn.-Mediated Carbon Quantum Dots

Carries no melanocortin or opioid receptor activity, isolating GHS-R1a pharmacology as a research tool

Cardiovascular outcomes, long-term efficacy and safety In people with T2D and established cardiovascular disease, the international guidelines for T2D recommend the use of GLP-1 RA or sodium glucose co-transporters 2 inhibitors (SGLT-2i) as first-line treatment (independent of HbA1c), based on multiple trials demonstrating their cardio-renal benefits [109]

It was recommended by my health care provider to help with poor sleeping and pain issues